Browsing Faculty of Health Sciences (FHS) by Author "Schmidt, C"
Now showing items 1-9 of 9
-
Cardiac safety/events in clinical trials with preventive HIV vaccine candidates based on Modified vaccinia Ankara (MVA)
Schmidt, C; Kochhar, S; Excler, JL; Smith, C; McMichael, A; Bwayo, J; Jaoko, WG; Weber, J; Kaleebu, P; Peters, B; Pantaleo, G; Vardas, E; Robinson, A; Ho, D; Keefer, M; Ramanathan, VD; Rosanne, Boyle; Fast, P (University of NairobiSchool of Medicine, 2008) -
Challenges experienced by the clinical team during the conduct of HIV vaccine clinical trials in Kenya
Omosa-Manyonyi, G; Jaoko, WG; Wakasiaka, S; Bwayo, J; Ndinya-Achola, J; Schmidt, C; Bhatt, K; Ogutu, H; K’Owino, D; Dally, L; Malogo, R; Fast, P (University of NairobiSchool of Medicine, 2005) -
Challenges of use and compliance with effective contraceptives among female participants in preventive HIV vaccine trials The Kenyan experience.
Ogutu, H; Wakasiaka, S; Malogo, R; Ndambuki, R; Nyange, J; Omosa, G; Anzala, O; Bwayo, J; Fast, P; Schmidt, C; Verlinde, C; Smith, C; Ndinya-Achola, J; Jaoko, W (University of NairobiSchool of Medicine, 2007) -
HIV vaccine clinical trials enrollment and retention: Experience from Kenya AIDS Vaccine Initiative
Omosa-Manyonyi, G; Jaoko, WG; Wakasiaka, S; Bwayo, J; Anzala, AO; Schmidt, C; Oyaro, M; Ogutu, H; Farah, B; Nyange, J; Bender, B; Odada, J; Fast, P; Verlinde, C (University of NairobiSchool of Medicine, 2005) -
Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa
Schmidt, C; Jaoko, W; Pontiano, K; Karita, E; Lehraman, J; Allen, S; Dally, L; Smith, C; Fast, P (University of Nairobi, 2009-10) -
Safety and immunogenicity of DNA and MVA HIVA vaccines in Phase-1 vaccine trials in Nairobi, Kenya
Jaoko, WG; Omosa, G; Bhatt, K; Matu, L; Ogutu, H; Wakasiaka, S; Odada, J; Anzala, O; Bashir, F; Oyaro, M; Indangasi, J; Ndinya-Achola, J; Schmidt, C; Hanke, T; McMichael, A; Fast, P; Bwayo, J (University of NairobiSchool of Medicine, 2004) -
Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults (2009).
Omosa-Manyonyi, G; Jaoko, W; Anzala, O; Ogutu, H; Ndambuki, R; Wakasiaka, S; Malogo, R; Kayitenkore, K; Karita, E; Schmidt, C; Fast, P; Komaroff, W; Cooper, A; Boaz, M; Gilmour, J; Dally, L; Ho, M; Smith, C; Graham, B (University of NairobiSchool of Medicine, 2009) -
Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults.
ayitenkore, K; Omosa-Manyonyi, G; Bwayo, J; Karita, E; Jaoko, WG; Schmidt, C; Gilmour, J; Boaz, M; Than, S; Graham, B (University of NairobiSchool of Medicine, 2007) -
Safety profile of DNA and MVA HIV preventive vaccines
Jaoko, WG; Manyonyi, GO; Bhatt, KM; Wakasiaka, S; Ogutu, H; Bashir, FM; Anzala, AO; Oyugi, M; Schmidt, C; Ongeri, M; Waruingi, W; Nyange, J; Indangasi, J; Bwayo, JJ; Ndinya-Achola, J; Mbori-Ngacha, D; Ngugi, E; Fast, P (University of NairobiSchool of Medicine, 2004)